Effects of L-arginine supplementation on biomarkers of glycemic control: a systematic review and meta‐analysis of randomised clinical trials

References

• Bahrami, D., Mozaffari-Khosravi, H., and Zavar-Reza, J., 2019. The effect of oral L-arginine supplementation on lipid profile, glycemic status, and insulin resistance in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled trial. Mediterranean journal of nutrition and metabolism, 12 (1), 12–79.
   Web of Science ®Google Scholar
• Balon, T.W., and Nadler, J.L., 1994. Nitric oxide release is present from incubated skeletal muscle preparations. Journal of applied physiology, 77 (6), 2519–2521.
   PubMed Web of Science ®Google Scholar
• Barbul, A., 1986. Arginine: biochemistry, physiology, and therapeutic implications. JPEN. Journal of parenteral and enteral nutrition, 10 (2), 227–238.
   PubMed Web of Science ®Google Scholar
• Bogdanski, P., et al., 2012. Effect of 3-month L-arginine supplementation on insulin resistance and tumor necrosis factor activity in patients with visceral obesity. European review for medical and pharmacological sciences, 16 (6), 816–823.
   PubMed Web of Science ®Google Scholar
• Böger, R.H., 2008. L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous? Current opinion in clinical nutrition and metabolic care, 11 (1), 55–61.
   PubMed Web of Science ®Google Scholar
• Bornfeldt, K.E., and Tabas, I., 2011. Insulin resistance, hyperglycemia, and atherosclerosis. Cell metabolism, 14 (5), 575–585.
   PubMed Web of Science ®Google Scholar
• Cable, D.G., et al., 2009. Asymmetric dimethylarginine endogenous inhibition of nitric oxide synthase causes differential vasculature effects. Medical science monitor, 15, BR248–BR253.
   PubMed Web of Science ®Google Scholar
• Clarkson, P., et al., 1996. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. Journal of clinical investigation, 97 (8), 1989–1994.
   PubMed Web of Science ®Google Scholar
• Dashtabi, A., et al., 2016. Oral L-arginine administration improves anthropometric and biochemical indices associated with cardiovascular diseases in obese patients: a randomized, single blind placebo controlled clinical trial. Research in cardiovascular medicine, 5. doi:10.5812/cardiovascmed.29419
   PubMedGoogle Scholar
• de Castro Barbosa, T., et al., 2013. L-Arginine enhances glucose and lipid metabolism in rat L6 myotubes via the NO/ c-GMP pathway . Metabolism: clinical and experimental, 62 (1), 79–89.
   PubMed Web of Science ®Google Scholar
• DeFronzo, R.A., et al., 2015. Type 2 diabetes mellitus. Nature reviews disease primers, 1, 15019
   PubMed Web of Science ®Google Scholar
• Faldetta, M.C., et al., 2002. L-arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in Type II diabetic patients. Diabetologia, 45 (8), 1120–1127.
   PubMed Web of Science ®Google Scholar
• Flynn, N., et al., 2002. The metabolic basis of arginine nutrition and pharmacotherapy. Biomedicine & pharmacotherapy = biomedecine & pharmacotherapie, 56 (9), 427–438.
   PubMed Web of Science ®Google Scholar
• Follmann, D., et al., 1992. Variance imputation for overviews of clinical trials with continuous response. Journal of clinical epidemiology, 45 (7), 769–773.
   PubMed Web of Science ®Google Scholar
• Gannon, M.C., Nuttall, J.A., and Nuttall, F.Q., 2002. Oral arginine does not stimulate an increase in insulin concentration but delays glucose disposal. The American journal of clinical nutrition , 76 (5), 1016–1022.
   PubMed Web of Science ®Google Scholar
• Gatto, C., 2010. NO control: nitric oxide directly regulates substrate delivery to NOS. Focus on “Nitric oxide can acutely modulate its biosynthesis through a negative feedback mechanism on l-arginine transport in cardiac myocytes. American journal of physiology , 299 (2), C213–C215.
   Google Scholar
• Gupta, D., B Krueger, C., and Lastra, G., 2012. Over-nutrition, obesity and insulin resistance in the development of β-cell dysfunction. Current diabetes reviews, 8 (2), 76–83.
   PubMedGoogle Scholar
• Higgins, J.P., et al., 2011. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (Clinical Research ed.), 343, d5928.
   PubMed Web of Science ®Google Scholar
• Jobgen, W.S., et al., 2006. Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. Journal of nutritional biochemistry , 17 (9), 571–588.
   PubMed Web of Science ®Google Scholar
• Kahn, S., 2003. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia, 46 (1), 3–19.
   PubMed Web of Science ®Google Scholar
• Kahn, S.E., Hull, R.L., and Utzschneider, K.M., 2006. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 444 (7121), 840–846.
   PubMed Web of Science ®Google Scholar
• Klein, S., et al., 2004. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation, 110, 2952–2967.
   PubMed Web of Science ®Google Scholar
• Lubec, B., et al., 1997. L-Arginine reduces lipid peroxidation in patients with diabetes mellitus. Free radical biology and medicine, 22 (1–2), 355–357.
   PubMed Web of Science ®Google Scholar
• Lucotti, P., et al., 2009. Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass. Metabolism, 58 (9), 1270–1276.
   PubMed Web of Science ®Google Scholar
• Lucotti, P., et al., 2006. Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients. American journal of physiology-endocrinology and metabolism, 291 (5), E906–E912.
   PubMed Web of Science ®Google Scholar
• McKnight, J.R., et al., 2010. Beneficial effects of L-arginine on reducing obesity: potential mechanisms and important implications for human health. Amino acids, 39 (2), 349–357.
   PubMed Web of Science ®Google Scholar
• McNeal, C.J., et al., 2016. Safety and effectiveness of arginine in adults. The journal of nutrition, 146 (12), 2587S–2593S.
   PubMed Web of Science ®Google Scholar
• McNeal, C.J., et al., 2018. Safety of dietary supplementation with arginine in adult humans. Amino acids, 50 (9), 1215–1229.
   PubMed Web of Science ®Google Scholar
• McRae, M.P., 2016. Therapeutic benefits of l-arginine: an umbrella review of meta-analyses. Journal of chiropractic medicine, 15 (3), 184–189.
   PubMed Web of Science ®Google Scholar
• Menge, B.A., et al., 2010. Selective amino acid deficiency in patients with impaired glucose tolerance and type 2 diabetes. Regulatory peptides, 160 (1–3), 75–80.
   PubMedGoogle Scholar
• Mohamadin, A.M., et al., 2007. Can nitric oxide-generating compounds improve the oxidative stress response in experimentally diabetic rats? Clinical and experimental pharmacology & physiology, 34 (7), 586–593.
   PubMed Web of Science ®Google Scholar
• Moher, D., et al., 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine, 151 (4), 264–269.
   PubMed Web of Science ®Google Scholar
• Monti, L.D., et al., 2018. Decreased diabetes risk over 9 year after 18-month oral L-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of L-arginine study). European journal of nutrition, 57 (8), 2805–2817.
   PubMed Web of Science ®Google Scholar
• Monti, L., et al., 2012. Effect of a long‐term oral l‐arginine supplementation on glucose metabolism: a randomized, double‐blind, placebo‐controlled trial. Diabetes, obesity and metabolism, 14 (10), 893–900.
   PubMed Web of Science ®Google Scholar
• Monti, L., et al., 2000. Effects of endothelin-1 and nitric oxide on glucokinase activity in isolated rat hepatocytes. Metabolism: clinical and experimental, 49 (1), 73–80.
   PubMed Web of Science ®Google Scholar
• Nazarian, B., et al., 2019. Effect of L-arginine supplementation on C-reactive protein and other inflammatory biomarkers: a systematic review and meta-analysis of randomized controlled trials. Complementary therapies in medicine, 47, 102226.
   PubMed Web of Science ®Google Scholar
• Ogurtsova, K., et al., 2017. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes research and clinical practice, 128, 40–50.
   PubMed Web of Science ®Google Scholar
• Pahlavani, N., et al., 2014. L-arginine supplementation and risk factors of cardiovascular diseases in healthy men: a double-blind randomized clinical trial. F1000Research, 3, 306.
   PubMedGoogle Scholar
• Palmer, R.M., Ashton, D., and Moncada, S., 1988. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 333 (6174), 664–666.
   PubMed Web of Science ®Google Scholar
• Petrie, J.R., et al., 1996. Endothelial nitric oxide production and insulin sensitivity: a physiological link with implications for pathogenesis of cardiovascular disease. Circulation, 93 (7), 1331–1333.
   PubMed Web of Science ®Google Scholar
• Phillips, L.S., et al., 2006. All pre-diabetes is not the same: metabolic and vascular risks of impaired fasting glucose at 100 versus 110 mg/dl: the Screening for Impaired Glucose Tolerance study 1 (SIGT 1). Diabetes care, 29 (6), 1405–1407.
   PubMed Web of Science ®Google Scholar
• Piatti, P.M., et al., 2001. Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. Diabetes care, 24 (5), 875–880.
   PubMed Web of Science ®Google Scholar
• Pourghasem Gargari, B., et al., 2015. Effect of L-arginine and selenium on metabolic features, insulin resistance and hepatic function tests in obese women. Current nutrition & food science, 11, 1–6.
   Web of Science ®Google Scholar
• Ramakrishnan, S., et al., 2002. Effect of oral supplementation of free amino acids in type 2 diabetic patients: a pilot clinical trial. Medical science monitor, 8, CR131–CR137.
   PubMedGoogle Scholar
• Seidell, J.C., 2000. Obesity, insulin resistance and diabetes—a worldwide epidemic. British journal of nutrition, 83 (S1), S5–S8.
   PubMed Web of Science ®Google Scholar
• Sepandi, M., et al., 2019. Effect of L-Arginine supplementation on lipid profiles and inflammatory markers: a systematic review and meta-analysis of randomized controlled trials. Pharmacological research, 148, 104407.
   PubMed Web of Science ®Google Scholar
• Siani, A., et al., 2000. Blood pressure and metabolic changes during dietary L-arginine supplementation in humans. American journal of hypertension, 13 (5 Pt 1), 547–551.
   PubMed Web of Science ®Google Scholar
• Suliburska, J., et al., 2014. Changes in mineral status are associated with improvements in insulin sensitivity in obese patients following L-arginine supplementation. European journal of nutrition, 53 (2), 387–393.
   PubMed Web of Science ®Google Scholar
• Wascher, T., et al., 1997. Effects of low‐dose l‐arginine on insulin‐mediated vasodilatation and insulin sensitivity. European journal of clinical investigation, 27 (8), 690–695.
   PubMed Web of Science ®Google Scholar
• Wu, G., 2009. Amino acids: metabolism, functions, and nutrition. Amino acids, 37 (1), 1–17.
   PubMed Web of Science ®Google Scholar
• Wu, G., et al., 2007. Pharmacokinetics and safety of arginine supplementation in animals. The journal of nutrition, 137 (6 Suppl 2), 1673S–1680S.
   PubMed Web of Science ®Google Scholar
• Wu, G., and Meininger, C.J., 2000. Arginine nutrition and cardiovascular function. The journal of nutrition, 130 (11), 2626–2629.
   PubMed Web of Science ®Google Scholar
• Wu, G., and Meininger, C.J., 2009. Nitric oxide and vascular insulin resistance. Biofactors (Oxford, England), 35 (1), 21–27.
   PubMed Web of Science ®Google Scholar
• Wu, G., and Morris, S.M., Jr, 1998. Arginine metabolism: nitric oxide and beyond. Biochemical journal, 336 (1), 1–17.
   PubMed Web of Science ®Google Scholar
• Xie, F., Chan, J.C., and Ma, R.C., 2018. Precision medicine in diabetes prevention, classification and management. Journal of diabetes investigation, 9 (5), 998–1015.
   PubMed Web of Science ®Google Scholar
• Zheng, Y., Ley, S.H., and Hu, F.B., 2018. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews Endocrinology, 14 (2), 88–98.
   PubMed Web of Science ®Google Scholar